3 ms·
There is an easy fix but nobody would stand for it: do full longitudinal surveillance of all tests. That is, the gent with the “narrowed” arteries could be fol
by gumby 5y ago
There is an easy fix but nobody would stand for it: do full longitudinal surveillance of all tests. That is, the gent with the “narrowed” arteries could be followed to see if it becomes a problem (a lot of the metrics are, to simplify, fairly arbitrary and based on a small observational n). Perhaps he does have a stroke, perhaps not.
Of course no one would stand for such an intrusive system. But over time it would improve diagnosis.
- SemanticStrengh 5y agoanonymised data about prescription correlations and symptom metrics is the #1 missed opportunity of mankind progress. The tragic fact is, for most drug we have zero clue what they're doing to your body after a 6month-1 year period, nor do we know what do the combinatorial explosion of polypharmacical interactions do. There are people currently living the dream of increased lifepsan/healspan by getting lucky on that pharmacological lottery ticket and other (most) are living the invisible damage nightmare.
- cryoz 5y ago> the gent with the “narrowed” arteries could be followed How exactly would you follow? Stress testing, angiography, cardiac MR, CCTA??
- gumby 4y agoNo, just basic outcome. If the data were collected someone could look to see if people with narrowed cerebral arteries suffered, say, more strokes. If such a correlation were found, more intervention would indicated, if not, then not. It’s a pretty slow process, but outcome is what really matters, and even if slow it would be faster than doing nothing.